A detailed history of Hhm Wealth Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Hhm Wealth Advisors, LLC holds 200 shares of MRNA stock, worth $7,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$7,370
Previous $23,000 43.48%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$135.66 - $197.02 $2,713 - $3,940
-20 Reduced 9.09%
200 $30,000
Q2 2022

Aug 08, 2022

BUY
$117.13 - $176.59 $2,342 - $3,531
20 Added 10.0%
220 $31,000
Q3 2021

Nov 02, 2021

SELL
$221.9 - $484.47 $5,547 - $12,111
-25 Reduced 11.11%
200 $77,000
Q2 2021

Jul 27, 2021

SELL
$129.91 - $234.98 $3,247 - $5,874
-25 Reduced 10.0%
225 $53,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $7,417 - $20,000
250 New
250 $16,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Hhm Wealth Advisors, LLC Portfolio

Follow Hhm Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hhm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hhm Wealth Advisors, LLC with notifications on news.